Back to Articles

Manufacturing of CD19/CD20 Bispecific CAR-T Cell Therapy (IMPT-514) for the Treatment of Systemic Lupus Erythematosus

pipeline background

Chen X, et al. Poster presentation at the 8th Annual CAR-TCR Summit in Boston. August 2023

Connect with us on LinkedIn, or get in touch via email.

Linkedin Envelope

Menu

Contact

United States

8501 Fallbrook Avenue, Suite 200

West Hills, CA 91304 USA

info@immpact-bio.com

(818) 857-4828

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.